Senzime Investor Relations Material
Latest events
Q2 2025
Senzime
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Senzime
Access all reports
Senzime AB is a medical technology company specializing in patient monitoring systems designed to enhance safety and efficiency in healthcare. The company develops and manufactures solutions for monitoring neuromuscular function and other critical physiological parameters during and after surgery. Senzime’s products aim to reduce complications, improve outcomes, and support personalized care in operating rooms and recovery units. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm Stock Exchange.
Key slides for Senzime
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
SEZI
Country
🇸🇪 Sweden